PURPOSE: The purpose of this study was to investigate perfusion of rectal tumors and to determine early responses to short-course hypofractionated radiotherapy (RT). MATERIAL AND METHODS: Twenty-three rectal cancer patients were included, which underwent perfusion-CT imaging before (pre-scan) and after treatment (post-scan). Contrast-enhancement was measured in tumor and muscle tissues and in the external iliac artery. Perfusion was quantified with three pharmacokinetic parameters: K(trans), v(e) and v(p). Perfusion differences between tumor and normal tissue and changes of the pharmacokinetic parameters between both scans were evaluated. RESULTS: The median tumors K(trans) values increased significantly from the pre-scan (0.36+/-0.11 (min(-1))) to the post-scan (0.44+/-0.13 (min(-1))) (p<0.001). Also, histogram analysis showed a shift of tumor voxels from lower K(trans) values towards higher K(trans) values. Furthermore, the median K(trans) values were significantly higher for tumor than for muscle tissue on both the pre-scan (0.10+/-0.05 (min(-1)), p<0.001) and the post-scan (0.10+/-0.04 (min(-1)), p<0.001). In contrast, no differences between tumor and muscle tissues were found for v(e) and v(p). Also, no significant differences were observed for v(e) and v(p) between the two pCT-imaging time-points. CONCLUSIONS: Hypofractionated radiotherapy of rectal cancer leads to an increased tumor perfusion as reflected by an elevated K(trans), possibly improving the bioavailability of cytotoxic agents in rectal tumors, often administered early after radiotherapy treatment. Copyright 2009 Elsevier Ireland Ltd. All rights reserved.
PURPOSE: The purpose of this study was to investigate perfusion of rectal tumors and to determine early responses to short-course hypofractionated radiotherapy (RT). MATERIAL AND METHODS: Twenty-three rectal cancerpatients were included, which underwent perfusion-CT imaging before (pre-scan) and after treatment (post-scan). Contrast-enhancement was measured in tumor and muscle tissues and in the external iliac artery. Perfusion was quantified with three pharmacokinetic parameters: K(trans), v(e) and v(p). Perfusion differences between tumor and normal tissue and changes of the pharmacokinetic parameters between both scans were evaluated. RESULTS: The median tumors K(trans) values increased significantly from the pre-scan (0.36+/-0.11 (min(-1))) to the post-scan (0.44+/-0.13 (min(-1))) (p<0.001). Also, histogram analysis showed a shift of tumor voxels from lower K(trans) values towards higher K(trans) values. Furthermore, the median K(trans) values were significantly higher for tumor than for muscle tissue on both the pre-scan (0.10+/-0.05 (min(-1)), p<0.001) and the post-scan (0.10+/-0.04 (min(-1)), p<0.001). In contrast, no differences between tumor and muscle tissues were found for v(e) and v(p). Also, no significant differences were observed for v(e) and v(p) between the two pCT-imaging time-points. CONCLUSIONS: Hypofractionated radiotherapy of rectal cancer leads to an increased tumor perfusion as reflected by an elevated K(trans), possibly improving the bioavailability of cytotoxic agents in rectal tumors, often administered early after radiotherapy treatment. Copyright 2009 Elsevier Ireland Ltd. All rights reserved.
Authors: M Protopapa; V Kouloulias; A Kougioumtzopoulou; Z Liakouli; C Papadimitriou; A Zygogianni Journal: Clin Transl Oncol Date: 2019-06-28 Impact factor: 3.405
Authors: Aadil A Khan; James T Paget; Martin McLaughlin; Joan N Kyula; Michelle J Wilkinson; Timothy Pencavel; David Mansfield; Victoria Roulstone; Rohit Seth; Martin Halle; Navita Somaiah; Jessica K R Boult; Simon P Robinson; Hardev S Pandha; Richard G Vile; Alan A Melcher; Paul A Harris; Kevin J Harrington Journal: Sci Transl Med Date: 2018-01-24 Impact factor: 17.956
Authors: Esme J Hill; Corran Roberts; Jamie M Franklin; Monica Enescu; Nicholas West; Thomas P MacGregor; Kwun-Ye Chu; Lucy Boyle; Claire Blesing; Lai-Mun Wang; Somnath Mukherjee; Ewan M Anderson; Gina Brown; Susan Dutton; Sharon B Love; Julia A Schnabel; Phil Quirke; Ruth Muschel; William G McKenna; Michael Partridge; Ricky A Sharma Journal: Clin Cancer Res Date: 2016-02-09 Impact factor: 12.531
Authors: Esther A Kleibeuker; Emmanouil Fokas; Philip D Allen; Veerle Kersemans; Arjan W Griffioen; John Beech; Jaehong H Im; Sean C Smart; Kitty C Castricum; Jaap van den Berg; Iris A Schulkens; Sally A Hill; Adrian L Harris; Ben J Slotman; Henk M Verheul; Ruth J Muschel; Victor L Thijssen Journal: Oncotarget Date: 2016-11-22
Authors: Roberto García-Figueiras; Sandra Baleato-González; Anwar R Padhani; Ana Marhuenda; Antonio Luna; Lidia Alcalá; Ana Carballo-Castro; Ana Álvarez-Castro Journal: Insights Imaging Date: 2016-04-30